Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand … J Huang, D Liu, Y Wang, L Liu, J Li, J Yuan, Z Jiang, Z Jiang, WLW Hsiao, ... Gut 71 (4), 734-745, 2022 | 213 | 2022 |
A review of therapeutic agents and Chinese herbal medicines against SARS-COV-2 (COVID-19) F Huang, Y Li, ELH Leung, X Liu, K Liu, Q Wang, Y Lan, X Li, H Yu, L Cui, ... Pharmacological research 158, 104929, 2020 | 146 | 2020 |
Exploring the emerging role of the gut microbiota and tumor microenvironment in cancer immunotherapy Q Qiu, Y Lin, Y Ma, X Li, J Liang, Z Chen, K Liu, Y Huang, H Luo, R Huang, ... Frontiers in immunology 11, 612202, 2021 | 93 | 2021 |
Recent progress on targeting ferroptosis for cancer therapy LL Guangxiang Xu, HanWang, Xiaoling Li, Riming Huang Biochemical Pharmacology 114584, 2021 | 79 | 2021 |
Proscillaridin A induces apoptosis and suppresses non-small-cell lung cancer tumor growth via calcium-induced DR4 upregulation RZ Li, XX Fan, FG Duan, ZB Jiang, HD Pan, LX Luo, YL Zhou, Y Li, ... Cell death & disease 9 (6), 696, 2018 | 52 | 2018 |
Honokiol induces apoptosis, G1 arrest, and autophagy in KRAS mutant lung cancer cells LX Luo, Y Li, ZQ Liu, XX Fan, FG Duan, RZ Li, XJ Yao, ELH Leung, L Liu Frontiers in pharmacology 8, 199, 2017 | 52 | 2017 |
Inhibition of KRAS-dependent lung cancer cell growth by deltarasin: blockage of autophagy increases its cytotoxicity ELH Leung, LX Luo, ZQ Liu, VKW Wong, LL Lu, Y Xie, N Zhang, YQ Qu, ... Cell death & disease 9 (2), 216, 2018 | 48 | 2018 |
Molecular mechanisms of ferroptosis and relevance to inflammation L Deng, S He, N Guo, W Tian, W Zhang, L Luo Inflammation Research 72 (2), 281-299, 2023 | 47 | 2023 |
Targeting ferroptosis-based cancer therapy using nanomaterials: Strategies and applications L Luo, H Wang, W Tian, X Li, Z Zhu, R Huang, H Luo Theranostics 11 (20), 9937, 2021 | 44 | 2021 |
Suppression of Lipogenesis via Reactive Oxygen Species–AMPK Signaling for Treating Malignant and Proliferative Diseases XX Fan, ELH Leung, Y Xie, ZQ Liu, YF Zheng, XJ Yao, LL Lu, JL Wu, ... Antioxidants & redox signaling 28 (5), 339-357, 2018 | 43 | 2018 |
Chemical composition and pharmacological mechanism of ephedra-glycyrrhiza drug pair against coronavirus disease 2019 (COVID-19) X Li, Q Qiu, M Li, H Lin, S Cao, Q Wang, Z Chen, W Jiang, W Zhang, ... Aging (Albany NY) 13 (4), 4811, 2021 | 39 | 2021 |
Structure-based pharmacophore modeling, virtual screening, molecular docking, ADMET, and molecular dynamics (MD) simulation of potential inhibitors of PD-L1 from the library of … L Luo, A Zhong, Q Wang, T Zheng Marine Drugs 20 (1), 29, 2021 | 37 | 2021 |
Identification of a new inhibitor of KRAS‐PDEδ interaction targeting KRAS mutant nonsmall cell lung cancer ELH Leung, LX Luo, Y Li, ZQ Liu, LL Li, DF Shi, Y Xie, M Huang, LL Lu, ... International Journal of Cancer 145 (5), 1334-1345, 2019 | 36 | 2019 |
STAT3-mediated ferroptosis is involved in ulcerative colitis F Huang, S Zhang, X Li, Y Huang, S He, L Luo Free Radical Biology and Medicine 188, 375-385, 2022 | 33 | 2022 |
Astaxanthin attenuates ferroptosis via Keap1-Nrf2/HO-1 signaling pathways in LPS-induced acute lung injury L Luo, F Huang, S Zhong, R Ding, J Su, X Li Life Sciences 311, 121091, 2022 | 32 | 2022 |
Fucoxanthin attenuates LPS-induced acute lung injury via inhibition of the TLR4/MyD88 signaling axis X Li, R Huang, K Liu, M Li, H Luo, L Cui, L Huang, L Luo Aging (albany NY) 13 (2), 2655, 2021 | 32 | 2021 |
Structural characterization, and in vitro immunostimulatory and antitumor activity of an acid polysaccharide from Spirulina platensis B Cai, X Zhao, L Luo, P Wan, H Chen, J Pan International Journal of Biological Macromolecules 196, 46-53, 2022 | 28 | 2022 |
Parthenolide inhibits the growth of non-small cell lung cancer by targeting epidermal growth factor receptor X Li, R Huang, M Li, Z Zhu, Z Chen, L Cui, H Luo, L Luo Cancer Cell International 20, 1-11, 2020 | 27 | 2020 |
Targeting ferroptosis for cancer therapy: iron metabolism and anticancer immunity L Luo, H Wang, W Tian, J Zeng, Y Huang, H Luo American Journal of Cancer Research 11 (11), 5508, 2021 | 25 | 2021 |
Development of small molecule inhibitors/agonists targeting STING for disease K Liu, Y Lan, X Li, M Li, L Cui, H Luo, L Luo Biomedicine & Pharmacotherapy 132, 110945, 2020 | 24 | 2020 |